• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Electron microscopy and a sequence-independent, single-primer amplification (SISPA) viromics approach for monkeypox virus genome determination - Virol

Mary Wilson

Well-known member
September 14 2022

Electron microscopy and a sequence-independent, single-primer amplification (SISPA) viromics approach for monkeypox virus genome determination

Nicola Fletcher 1,2*,†, Gabriel Gonzalez 3,4†, Luke Meredith 5†, Tiina O’Neill 2, Kevin Purves 1,2, Daniel Hare 3, Brian Keogan 3, Charlene Bennett 3, Joanne Moran 3, Sophie O’Reilly 6, Lili Gu 6, Matthew Angeliadis 6, Marion Pouget 6, Dimitri Scholz 2, Virginie Gautier 6, Patrick Mallon 6,7, Stephen Gordon 1,2, Jonathan Dean 3, Jeff Connell 3, Michael Carr 3,4, Cillian De Gascun 3*.
​​​​

Monkeypox is a viral zoonosis endemic in West and Central Africa and presents clinically in humans as a smallpox-like illness (Bunge et al., 2022). Monkeypox virus (MPXV) is an enveloped virus with a particle size of ca. 300×240 nm containing a double-stranded DNA genome of ~197 kb taxonomically classified in the family Poxviridae, genus Orthopoxvirus (Weaver and Isaacs, 2008).

There is increasing public health concern about the geographical spread and re-emergence of MPXV arising from the recent multi-country outbreaks, with more than 47 206 cases reported in 92 non-endemic countries since the first case was laboratory confirmed in the United Kingdom on the 7th of May 2022 (updated August 28th 2022 (CDC, 2022)). The MPXV genome reported (GenBank ON872184) here was from a laboratory-confirmed Irish case (Orthopox group RNA and MPXV-specific RNA detection by real-time PCR) identified in June 2022. Transmission electron microscopy (TEM) of a lesion swab sample collected visualised multiple characteristic brick-shaped poxvirus virions with lattice-like surface detail (Fig. 1). We performed a sequence-independent, single-primer amplification (SISPA) viromics approach to achieve a non-selective (unbiased) amplification of viral RNA transcripts and here report horizontal genome coverage over 90% with an average vertical coverage (depth) between 9x and 21x. Phylogenetic analysis with 35 publicly available international MPXV genome sequences from multiple countries (UK, Israel, Nigeria, USA, Singapore and Portugal) sampled between 2017-2019 and 2022 (Happi et al.), demonstrated high sequence similarity to other cases circulating in the 2022 outbreak in Europe and USA clustered together in clade 3 (Happi et al.); with the Irish MPXV genome further clustered in the B.1 lineage (Fig. 2). ...

https://virological.org/t/electron-m...ermination/899
 
Back
Top